Device Compatibility Sample Clauses

Device Compatibility. Some devices may not be compatible with certain data and email price plans or access point names, details of which can be provided on request.
Sample 1Sample 2Sample 3See All (5)
AutoNDA by SimpleDocs
Device Compatibility. The Mobile Application currently only works on certain compatible electronic devices or smartphones and other devices as determined by Merchantrade. Merchantrade may change the version of the operating system that works with the Mobile App at any time. Some features may not be available on all platforms or operating systems.
Sample 1Sample 2Sample 3
Device Compatibility. The Application currently only works on certain compatible smart phones and other devices as determined by Al Rajhi Bank Malaysia. Al Rajhi Bank Malaysia may change the version of the operating system that works with the Mobile Banking App, alrajhi@24seven and/or Secure@24seven at any time. 8.1.5.1 Some features may not be available on all platforms or operating systems. Detailed information on features, platforms and operating systems is available in the Website. 8.1.5.2 Al Rajhi Bank Malaysia shall not be responsible for any loss/damage to mobile device if Customer attempts to install Personal Mobile Banking App, alrajhi@24seven and/or register the Secure@24seven into non-compatible Mobile Devices;
Sample 1
Device Compatibility. The Application is designed to work when accessed through the internet by a computer using certain web browsers or certain portable devices (such as phones or tablets that use certain operating systems). You acknowledge and agree that some web browsers or portable devices may not be compatible with the Application.
Sample 1
Device Compatibility. 5.4.1 Within 30 days of the Effective Date the Parties will meet to discuss device roadmap requirements and Customized Software compatibility and establish a matrix of those devices which shall be supported by this Project. The Parties further agree to hold monthly meetings, as mutually agreed by the parties, for exposure to new device roadmaps, to prioritize devices for support, as determined by Verizon Wireless, and to discuss testing, device operating system client support requirements and demonstration units. Verizon Wireless will provide Intellisync with all devices and operating systems upon any changes to the devices or operating systems which Verizon Wireless deems as requiring re-certification. The device and operating system testing methodology is attached hereto as Exhibit 1 to Exhibit F to this Agreement. The Parties acknowledge that the testing methodology can be updated and modified upon mutual agreement of the parties. The Parties acknowledge that the Customized Software does not work on all mobile devices; rather, it works on those certified by Intellisync as compatible with the Customized Software. The Customized Software created by Intellisync will work with all devices that it has certified as compatible with the Software in its Product Functionality Document (Exhibit G to this Agreement) as of the Effective Date. For so long as Intellisync is providing managed services, Intellisync and Verizon Wireless shall continue to identify areas for Intellisync’s continuous improvement in cost, quality and service over the Term of the Agreement. Intellisync shall afford Verizon Wireless the ability to realize the benefit of such improvements, including possible price reductions, to the extent the Parties mutually agree. Furthermore, a list of continuous improvement initiatives may be created by the Parties. Unless otherwise set forth in this Agreement, Intellisync and Verizon Wireless may meet, as mutually agreed, to assess opportunities to implement potential continuous improvement initiatives and customer satisfaction issues, such initiatives and issues to be mutually agreed to by the Parties. Any device provided to Intellisync by Verizon Wireless shall Intellisync/Verizon Wireless Proprietary and Confidential CONFIDENTIAL TREATMENT not be used for the purpose of developing or certifying software over other wireless networks, and such devices are strictly protected under the confidentiality provisions of this Agreement.
Sample 1
Device Compatibility. Customer may only use devices that have been approved by Sprint to be used in connection with SBMF Services (the “Wireless Devices”), and will only allow individual liable users to participate in Customer’s use of SBMF Services after Customer has confirmed that such individual liable users will use approved Wireless Devices. Sprint has implemented a mechanism to restrict the ability to send User Invitations to devices that are not compatible with SBMF Services. The following Sprint devices are approved to be used in connection with SBMF Services: RIM Blackberry 7250, RIM Blackberry 7130e, Sanyo VI-2300, Sanyo MM-8300, Sanyo RL-4930, Sanyo MM-9000, Sanyo MM-7500, Sanyo SCP-200, Sanyo SCP-3100, Sanyo SCP-2400, Sanyo "Katana" (SCP-6600), Sanyo 8400, Sprint PPC-6600, Sprint PPC-6601, Sprint PPC-6700, Motorola c290, LG LX350, LG Fusic (LX 550), Samsung A580, Samsung A640, Samsung MM-A940, Samsung MM-A900, Samsung MM-A920, PalmOne Treo 650, PalmOne Treo 700p, Nokia 6165i, and Sendum VT-100. Sprint may update the list of Wireless Devices that are compatible with SBMF Services by notifying Customer or by posting an updated version of this Annex.
Sample 1
Device Compatibility uab mobile currently only works on certain compatible electronic devices or smartphones and other devices as determined by uab. uab may change the version of the operating system that works with the Mobile App at any time. Some features may not be available on all platforms or operating systems.
Sample 1
AutoNDA by SimpleDocs

Related to Device Compatibility

  • Compatibility 1. Any unresolved issue arising from a mutual agreement procedure case otherwise within the scope of the arbitration process provided for in this Article and Articles 25A to 25G shall not be submitted to arbitration if the issue falls within the scope of a case with respect to which an arbitration panel or similar body has previously been set up in accordance with a bilateral or multilateral convention that provides for mandatory binding arbitration of unresolved issues arising from a mutual agreement procedure case.

  • Stability 14.01 Maintain a documented, ongoing stability program to monitor the stability of the Product using stability indicating procedures. X 14.02 Data analysis and trending reporting will be performed. X

  • Configuration The configuration for the Purchase Right Aircraft will be the Detail Specification for Model 767-3S2F aircraft at the revision level in effect at the time of the Supplemental Agreement. Such Detail Specification will be revised to include (i) changes required to obtain required regulatory certificates and (ii) other changes as mutually agreed upon by Boeing and Customer.

  • Interfaces Bellcore’s GR-446-CORE defines the interface between the administration system and LIDB including specific message formats. (Bellcore’s TR-NWP-000029, Section 10)

  • Engineering Forest Service completed survey and design for Specified Roads prior to timber sale advertisement, unless otherwise shown in A8 or Purchaser survey and design are specified in A7. On those roads for which Forest Service completes the design during the contract, the design quantities shall be used as the basis for revising estimated costs stated in the Schedule of Items and adjusting Timber Sale Account. Forest Service engineering shall be completed according to the schedule in A8. Should Forest Service be unable to perform the designated survey and design by the completion date or other agreed to time, upon written agreement, Purchaser shall assume responsibility for such work. In such event, Contracting Officer shall revise:

  • Research Analyst Independence The Company acknowledges that the Underwriters’ research analysts and research departments are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters’ research analysts may hold views and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriters’ investment banking divisions. The Company acknowledges that each of the Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by this Agreement.

  • Inspection and Testing Each Constructing Entity shall cause inspection and testing of the Interconnection Facilities that it constructs in accordance with the provisions of this section. The Construction Parties acknowledge and agree that inspection and testing of facilities may be undertaken as facilities are completed and need not await completion of all of the facilities that a Constructing Entity is building.

  • Traceability 11.1 Under the terms of this Agreement, Supplier shall have and operate a process to ensure that all Products, sub-assemblies and the components contained therein supplied to the Buyer are completely Traceable back to manufacturer by batch or lot or date code.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, Registration Statement, the Pricing Disclosure Package or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with applicable laws, rules, regulations and policies of the Food and Drug Administration of the U.S. Department of Health and Human Services (the “FDA”) or any committee thereof or of any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are materially inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Pricing Disclosure Package or the Prospectus; for such studies that have been or are being conducted, the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by foreign government or drug or medical device regulatory agencies, or foreign health care facility Institutional Review Boards; and no investigational new drug application filed by or on behalf of the Company or any of its subsidiaries with the FDA has been terminated or suspended by the FDA, and neither the FDA nor any applicable foreign regulatory agency has commenced, or, to the knowledge of the Company, threatened to initiate, any action to place a clinical hold order on, or otherwise terminate, delay or suspend, any proposed or ongoing studies conducted or proposed to be conducted by or on behalf of the Company or any of its subsidiaries.

Time is Money Join Law Insider Premium to draft better contracts faster.